Functional Medicine Doctors and Peptides: What to Know

Key Takeaways

• FDA-approved peptides like semaglutide and tirzepatide have rigorous clinical trial backing and clear dosing guidelines, while unapproved peptides like BPC-157 and TB-500 lack large human safety studies and standardized dosing, requiring extra caution.
• Compounded peptides are not FDA-reviewed for safety or effectiveness before reaching patients, and compounding rules tightened significantly in 2025 after GLP-1 shortages ended, making verification of current legal status essential.
• Responsible peptide therapy requires baseline lab testing, regular monitoring visits, screening for contraindications, and clear tracking of side effects—never a standalone treatment without proper primary care oversight.
• Weight loss and diabetes management have strong evidence for FDA-approved peptides, while anti-aging and muscle recovery claims tied to unapproved peptides deserve skepticism without robust clinical evidence.

Peptide therapy is one of the fastest-growing topics in wellness care today. Patients hear about it online, ask about it at checkups, and often confuse different products with each other. Some peptides, like semaglutide and tirzepatide, are FDA-approved and backed by strong research. Others, like BPC-157 or TB-500, are still experimental and lack solid human safety data. Understanding the difference matters more than ever in 2026, as rules around compounded peptides have tightened and shortages of popular GLP-1 drugs have ended.

Functional medicine doctors often use the term "peptide therapy" loosely. It can mean a proven prescription medicine for diabetes or weight loss. Or it can mean an unproven compound marketed for anti-aging, muscle recovery, or hormone support. This guide breaks down what functional medicine doctors actually mean when they talk about peptides, which ones are safe and approved, and how a trustworthy primary care and wellness clinic should guide you through treatment.

What Do Functional Medicine Doctors Mean by Peptide Therapy?

Peptides are short chains of amino acids. Your body makes them naturally to control things like hormones, digestion, and immune response. In medicine, peptide therapy usually falls into two very different categories.

• FDA-approved peptide medicines: These are tested, regulated drugs with clear indications. Semaglutide, tirzepatide, liraglutide, dulaglutide, and exenatide fall into this group.
• Compounded or investigational peptides: These are often sold at wellness clinics for healing, longevity, or performance. Many lack large human trials or FDA approval for general use.

A responsible functional medicine approach to peptides should always start by identifying which category a treatment falls into. This distinction shapes everything from safety monitoring to legal compliance.

FDA-Approved Peptides: The Proven Options

Several peptide medicines have gone through rigorous clinical trials and received FDA approval. These are not experimental. They have known dosing, documented side effects, and specific approved uses.

Notably, Zepbound became the first medication approved for moderate-to-severe obstructive sleep apnea in adults with obesity in December 2024. This shows how quickly approved uses for these peptide medicines are expanding. Patients exploring medically supervised weight loss should understand these products are not interchangeable, even though they share similar mechanisms.

The Peptides Without FDA Approval for General Use

Many peptides marketed in wellness clinics do not have the same backing. These products are often sold online or through compounding pharmacies without strong clinical evidence.

1. BPC-157: Promoted for gut healing and tissue repair, but human trial data is limited.
2. TB-500 (thymosin beta-4 fragment): Marketed for injury recovery, without large-scale human safety studies.
3. CJC-1295: Often paired with growth hormone claims, lacking long-term human outcome data.
4. Ipamorelin: Sold for anti-aging and muscle growth, but not FDA-approved for these uses.
5. GHK-Cu (injectable): Used in skin and wound-healing claims, again without robust human trials.

This does not mean these peptides are automatically dangerous. It means the evidence is thinner, dosing standards vary, and quality control depends heavily on the source. A trustworthy clinic will be honest about these limitations rather than overselling results.

Why Compounded Peptides Require Extra Caution

Compounded drugs are made by pharmacies to meet specific patient needs. They are not the same as FDA-approved products. The FDA does not review compounded medicines for safety, effectiveness, or quality before they reach patients.

This distinction became especially important after GLP-1 shortages ended. The FDA announced that semaglutide injection shortages were resolved on February 21, 2025. Tirzepatide shortages were resolved as well. This led to new deadlines for compounding activity, including April 22, 2025, for certain 503A pharmacy compounding and May 22, 2025, for certain 503B outsourcing facilities. Rules can vary by product and legal situation, so patients should always confirm current status with their provider rather than assume older compounding practices still apply.

How a Responsible Functional Medicine Evaluation Should Work

Peptide therapy should never replace a solid primary care relationship. Instead, it should work alongside your regular medical care. Here is what a proper evaluation typically includes:

1. A full medical history and current medication review
2. Screening for contraindications, such as pancreatitis history or thyroid conditions
3. Baseline lab testing when appropriate for the treatment
4. Nutrition and physical activity counseling
5. A clear treatment plan with defined goals
6. Scheduled follow-up visits to track progress and side effects

This structured approach matters because peptide treatments, even FDA-approved ones, carry real risks that need monitoring. Skipping steps to save time or money can lead to complications that outweigh any benefit.

Common Side Effects and Safety Considerations

GLP-1 based medicines like semaglutide and tirzepatide come with a well-documented side effect profile. Most patients experience mild symptoms that improve over time, but some risks require closer attention.

• Nausea, vomiting, and diarrhea are the most common early complaints
• Constipation and reduced appetite often continue throughout treatment
• Dehydration can occur, especially with frequent vomiting
• Gallbladder disease and pancreatitis symptoms need prompt medical attention
• Hypoglycemia risk increases when combined with certain diabetes medications
• Loss of lean muscle mass can happen with rapid weight loss

For patients using non-approved peptides, the safety picture is less clear. Without large trials, dosing guidelines, and long-term data, it becomes harder to predict or manage adverse effects. This is one more reason to work with a provider who takes a cautious, evidence-based approach rather than following marketing trends.

How to Choose a Trustworthy Peptide Provider

Not every clinic offering peptide therapy operates with the same standards. Before starting treatment, ask these key questions:

1. Is this peptide FDA-approved, and for what specific indication?
2. What human clinical trials support its use for my condition?
3. How will my progress and side effects be monitored?
4. What pharmacy supplies this product, and is it properly licensed?
5. What baseline testing will happen before I start?
6. How often will I have follow-up appointments?

A clinic that cannot answer these questions clearly may not be the right choice. Patients in Tampa and Riverview looking for peptide therapy backed by real medical oversight should expect transparency about both benefits and limitations.

Why InCare Takes a Careful Approach to Peptide Therapy

At InCare, peptide therapy is treated as part of a larger primary care and wellness strategy, not a stand-alone quick fix. The team reviews your health history, checks for contraindications, and builds monitoring into every treatment plan. This matches the same standard InCare applies to cancer screenings, DNA gene testing, and other advanced wellness services.

InCare's team of providers includes physicians who understand both the promise and the limits of peptide medicine. Whether you are exploring semaglutide for weight management or asking about newer options discussed in peptide therapy trends for 2026, the goal is always safety first. You can find current locations and hours at the InCare locations page for Tampa and Riverview.

Lab Testing and Monitoring During Peptide Treatment

Lab work plays a central role in safe peptide therapy. Before starting, most patients benefit from baseline testing that may include:

• Comprehensive metabolic panel to check kidney and liver function
• Hemoglobin A1c for blood sugar trends
• Lipid panel to assess cardiovascular risk factors
• Thyroid function tests, especially before GLP-1 therapy
• Body composition analysis to track changes over time

Ongoing monitoring helps catch problems early and confirms the treatment is working as intended. InCare's body composition analysis uses advanced imaging to track results throughout treatment, giving both patients and providers clear data instead of guesswork.

Insurance and Cost Considerations

Coverage for peptide therapy varies widely. FDA-approved medicines like semaglutide and tirzepatide may be covered by insurance when prescribed for diabetes, though coverage for weight management alone is less consistent. Compounded or investigational peptides are almost never covered by insurance and are typically paid out of pocket. Patients should ask their provider for a clear breakdown of costs before starting any peptide program, including follow-up visits and lab testing fees.

Many patients researching options connect with clinics through social platforms first. Following a clinic's Facebook page or checking updates on Instagram can offer a sense of patient experiences and clinic culture before booking a consultation. Some clinics also share educational content on Tik Tok to help explain treatment options in simple terms.

Frequently Considered Questions Before Starting Peptide Therapy

Before committing to any peptide program, patients in Tampa and Riverview should weigh their personal health goals against the current evidence. Weight loss, diabetes management, and select FDA-approved uses have strong backing. Anti-aging, muscle recovery, and general wellness claims tied to unapproved peptides deserve more skepticism and a cautious, well-monitored approach if pursued at all.

If you are ready to discuss whether peptide therapy fits your health goals, InCare's team can walk you through your options with honest, evidence-based guidance. You can also check what current patients say by visiting Visit us on Google — InCare before scheduling your first visit.

Take the Next Step Toward Safe, Personalized Care

Peptide therapy can offer real benefits when it is matched to the right condition and monitored by an experienced medical team. The key is working with a provider who understands the science, respects the regulations, and puts your safety first. InCare's Tampa and Riverview locations combine primary care expertise with advanced wellness services, so you get guidance you can trust rather than guesswork.

Ready to find out if peptide therapy is right for you? Book Now to schedule a consultation, or Contact our team with any questions about your treatment options.

FAQs

Q: What do functional medicine doctors mean by peptide therapy?

A: The term covers two very different things: FDA-approved prescription peptides like semaglutide and tirzepatide, and compounded or investigational peptides marketed for wellness or anti-aging. A responsible provider will always clarify which category a specific treatment falls into before recommending it.

Q: Which peptides are FDA-approved for weight loss or diabetes?

A: Semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide, dulaglutide, and exenatide are all FDA-approved. Each has specific approved uses, so they should not be treated as interchangeable products.

Q: Are BPC-157, TB-500, CJC-1295, or ipamorelin FDA-approved?

A: No, none of these peptides currently have FDA approval for general human therapeutic use. They lack large-scale human trials, standardized dosing, and long-term safety data, so any use should involve careful medical oversight.

Q: Is compounded semaglutide or tirzepatide still legal and safe?

A: After the FDA confirmed that semaglutide and tirzepatide shortages were resolved in early 2025, compounding rules tightened significantly, with transition deadlines in April and May of that year. Patients should always verify current legal status with their provider rather than assume older compounding rules still apply.

Q: How should a primary care clinician monitor a patient taking peptide therapy?

A: Monitoring typically includes baseline lab testing, regular follow-up visits, tracking for side effects like nausea or gallbladder issues, and reassessing treatment goals over time. This structured approach applies to both FDA-approved and investigational peptides, though monitoring needs may differ.

Our Service Area